Shenzhen DeHe Biotech Co., Ltd. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2016

Location

Shenzhen Guangdong China

Primary Industry

Biotechnology

About

Based in Shenzhen, China and established in 2016, Shenzhen DeHe Biotech Co., Ltd. is a biotech company that provides artificial intelligence farming microalgae raw materials. The company has a subsidiary named Anhui Debao Biotechnology. It also set up a research and development center in Shanghai, and 7 branch offices. In July 2023, the firm closed series B funding led by new investor Shenzhen Fupeng Asset Management Co., LTD. In December 2023, DeHe Biotech closed series B+ funding. The company has a service platform for the whole industry chain of global B2B microalgae raw materials. It is committed to providing microalgae raw materials. The astaxanthin products offered by the company include red algae powder, red algae oil, astaxanthin microencapsulated powder and astaxanthin nanoemulsion. The company's products are used in pharmaceuticals, health care products, food and beverages, cosmetics and other fields. The company's new production base will be launched next year.

Current Investors

Goho AMC_Duplicate, Shenzhen Fupeng Asset Management Co., LTD, Pacific Pacer Holdings Limited

Request a demo to show more

Primary Industry

Biotechnology

Sub Industries

Biotechnology, Medicinal Chemicals & Botanicals

Company Stage

Series B

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.